LU85290A1 - Nouvelles formes galeniques du sulpiride utilisables par voie orale - Google Patents

Nouvelles formes galeniques du sulpiride utilisables par voie orale Download PDF

Info

Publication number
LU85290A1
LU85290A1 LU85290A LU85290A LU85290A1 LU 85290 A1 LU85290 A1 LU 85290A1 LU 85290 A LU85290 A LU 85290A LU 85290 A LU85290 A LU 85290A LU 85290 A1 LU85290 A1 LU 85290A1
Authority
LU
Luxembourg
Prior art keywords
sulpiride
type
weight
eudragit
dosage forms
Prior art date
Application number
LU85290A
Other languages
English (en)
French (fr)
Inventor
Guy Pitel
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ile De France filed Critical Ile De France
Publication of LU85290A1 publication Critical patent/LU85290A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
LU85290A 1983-12-23 1984-04-06 Nouvelles formes galeniques du sulpiride utilisables par voie orale LU85290A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8320635 1983-12-23
FR8320635A FR2556964A1 (fr) 1983-12-23 1983-12-23 Nouvelles formes galeniques du sulpiride utilisables par voie orale

Publications (1)

Publication Number Publication Date
LU85290A1 true LU85290A1 (fr) 1984-10-26

Family

ID=9295477

Family Applications (1)

Application Number Title Priority Date Filing Date
LU85290A LU85290A1 (fr) 1983-12-23 1984-04-06 Nouvelles formes galeniques du sulpiride utilisables par voie orale

Country Status (38)

Country Link
EP (1) EP0147244A1 (fi)
JP (1) JPS60139616A (fi)
KR (1) KR910004570B1 (fi)
AR (1) AR231398A1 (fi)
AU (1) AU569516B2 (fi)
BE (1) BE899331A (fi)
BG (1) BG49707A3 (fi)
CH (1) CH659386A5 (fi)
CZ (1) CZ262984A3 (fi)
DD (1) DD220782A5 (fi)
DE (1) DE3412868A1 (fi)
DK (1) DK165729C (fi)
ES (1) ES8502332A1 (fi)
FI (1) FI82603C (fi)
FR (1) FR2556964A1 (fi)
GB (1) GB2151920B (fi)
GR (1) GR79584B (fi)
HU (1) HU190924B (fi)
IE (1) IE57164B1 (fi)
IL (1) IL71470A (fi)
IN (1) IN160415B (fi)
IS (1) IS1364B6 (fi)
IT (1) IT1177655B (fi)
LU (1) LU85290A1 (fi)
MA (1) MA20088A1 (fi)
MX (1) MX7715E (fi)
NO (1) NO169575C (fi)
NZ (1) NZ207753A (fi)
OA (1) OA07700A (fi)
PH (1) PH21938A (fi)
PL (1) PL144356B1 (fi)
PT (1) PT78382B (fi)
RO (1) RO89437A (fi)
SU (1) SU1478993A3 (fi)
YU (1) YU44762B (fi)
ZA (1) ZA842573B (fi)
ZM (1) ZM2084A1 (fi)
ZW (1) ZW6084A1 (fi)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0164959A2 (en) * 1984-06-04 1985-12-18 Sterwin Ag. Pharmaceutical composition in sustained release unit dose form and process for its preparation

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3678643D1 (de) * 1985-08-16 1991-05-16 Procter & Gamble Partikel mit konstanter wirkstofffreisetzung.
US4853229A (en) * 1987-10-26 1989-08-01 Alza Corporation Method for adminstering tiny pills
JPH0791184B2 (ja) * 1988-03-31 1995-10-04 田辺製薬株式会社 放出制御型製剤およびその製法
GB8903328D0 (en) * 1989-02-14 1989-04-05 Ethical Pharma Ltd Nifedipine-containing pharmaceutical compositions and process for the preparation thereof
FR2762213B1 (fr) * 1997-04-18 1999-05-14 Synthelabo Composition pharmaceutique a retention gastrique

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3342826A (en) * 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
FR2313915A1 (fr) * 1976-01-26 1977-01-07 Corneille Gilbert Nouvelle forme galenique d'administration de la vincamine et de ses derives, son procede de preparation et medicaments comprenant cette nouvelle forme
US4285665A (en) * 1978-05-08 1981-08-25 Johnson, Matthey & Co., Limited Engines
FR2453639A1 (fr) * 1979-04-09 1980-11-07 Sanofi Sa Composition medicamenteuse a liberation programmee immediate-retard a base de naftidrofuryl
FR2453642A1 (fr) * 1979-04-12 1980-11-07 Sanofi Sa Compositions therapeutiques a usage oral et a liberation programmee du methanesulfonate de dihydroergotoxine
FR2454804B1 (fr) * 1979-04-26 1986-11-21 Sanofi Sa Medicament a base de dihydroergotoxine et son procede de preparation
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
SE8003805L (sv) * 1980-05-21 1981-11-22 Haessle Ab En farmaceutisk beredning med forbettrade utlosningsegenskap
JPS5753326A (en) * 1980-09-17 1982-03-30 Dainippon Printing Co Ltd Manufacture of biaxially stretching blow molded vessel of saturated polyester
FR2492661A1 (fr) * 1980-10-28 1982-04-30 Laruelle Claude Nouvelle forme galenique d'administration du metoclopramide, son procede de preparation et medicament comprenant cette nouvelle forme
FR2494112B1 (fi) * 1980-11-19 1986-01-10 Laruelle Claude
FR2534139B1 (fr) * 1982-10-07 1986-08-29 Laruelle Claude Nouvelle forme galenique du sulpiride, son procede de preparation et medicament comprenant cette nouvelle forme

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0164959A2 (en) * 1984-06-04 1985-12-18 Sterwin Ag. Pharmaceutical composition in sustained release unit dose form and process for its preparation
EP0164959A3 (en) * 1984-06-04 1986-12-17 Sterwin Ag. Pharmaceutical composition in sustained release unit dose form and process for its preparation

Also Published As

Publication number Publication date
PL144356B1 (en) 1988-05-31
GB2151920A (en) 1985-07-31
FI82603B (fi) 1990-12-31
FI82603C (fi) 1991-04-10
CZ262984A3 (en) 1995-07-12
EP0147244A1 (fr) 1985-07-03
FI841376A0 (fi) 1984-04-06
SU1478993A3 (ru) 1989-05-07
PL247098A1 (en) 1985-07-02
ES532125A0 (es) 1985-01-01
NZ207753A (en) 1987-08-31
IE840817L (en) 1985-06-23
IT8448001A1 (it) 1985-10-06
DK165729C (da) 1993-06-07
AR231398A1 (es) 1984-11-30
ZA842573B (en) 1984-11-28
DK180784D0 (da) 1984-04-06
BG49707A3 (en) 1992-01-15
NO169575B (no) 1992-04-06
BE899331A (fr) 1984-10-05
ZW6084A1 (en) 1984-08-08
ES8502332A1 (es) 1985-01-01
PH21938A (en) 1988-04-15
GB8408978D0 (en) 1984-05-16
FI841376A (fi) 1985-06-24
YU64084A (en) 1988-02-29
HU190924B (en) 1986-12-28
CH659386A5 (fr) 1987-01-30
MA20088A1 (fr) 1984-12-31
HUT35518A (en) 1985-07-29
PT78382B (fr) 1986-05-28
KR850005065A (ko) 1985-08-21
GR79584B (fi) 1984-10-30
IL71470A0 (en) 1984-07-31
IE57164B1 (en) 1992-05-20
PT78382A (fr) 1984-05-01
RO89437A (ro) 1986-06-30
DD220782A5 (de) 1985-04-10
OA07700A (fr) 1985-08-30
NO841367L (no) 1985-06-24
YU44762B (en) 1991-02-28
IL71470A (en) 1987-07-31
JPH0461848B2 (fi) 1992-10-02
IT8448001A0 (it) 1984-04-06
IS1364B6 (is) 1989-05-25
GB2151920B (en) 1987-09-23
ZM2084A1 (en) 1984-12-21
AU569516B2 (en) 1988-02-04
FR2556964A1 (fr) 1985-06-28
IN160415B (fi) 1987-07-11
AU2890484A (en) 1985-06-27
DK180784A (da) 1985-06-24
KR910004570B1 (ko) 1991-07-06
MX7715E (es) 1990-10-09
NO169575C (no) 1992-07-15
DE3412868A1 (de) 1985-07-11
IS2900A7 (is) 1984-11-14
JPS60139616A (ja) 1985-07-24
IT1177655B (it) 1987-08-26
DK165729B (da) 1993-01-11

Similar Documents

Publication Publication Date Title
EP2349217B1 (fr) Granulé d'acide gamma-hydroxybutyrique
CA2282082C (fr) Microgranules contenant du cisplatine
JP2881442B2 (ja) ジルチアゼムの遅放出性無酸医薬製剤及びその製法
EP1492531B3 (fr) Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiée d'amoxicilline
WO1982001649A1 (fr) Nouvelle forme galenique du fenofibrate, son procede d'obtention, son application comme medicament
FR2959935A1 (fr) Forme pharmaceutique orale alcoolo-resistante
CH662506A5 (fr) Composition pharmaceutique a absorption reglee de methyldopa.
EP1333812B1 (fr) Microgranules a base de principe actif et leur procede de fabrication
CA1200762A (en) Pharmaceutical preparation
EP0063132B1 (fr) Nouvelle forme galenique d'administration du metoclopramide, son procede de preparation et medicament comprenant cette nouvelle forme
EP1077687B1 (fr) Forme pharmaceutique multiparticulaire a liberation programmee et pulsee et son procede de preparation
EP1189602B1 (fr) Microgranules de sulfate de morphine, procede de preparation et composition les contenant
LU85290A1 (fr) Nouvelles formes galeniques du sulpiride utilisables par voie orale
EP2640364B1 (fr) Composition pharmaceutique comprenant du sel de bicarbonate, et son utilisation comme médicament dans le traitement et/ou la prévention des lithiases urinaires et des maladies liées
EP0145558B1 (fr) Nouvelles formes galéniques du sulpiride utilisables par voie orale
EP2640365B1 (fr) Composition pharmaceutique comprenant du sel precurseur du cycle de krebs, en particulier du sel de citrate, et son utilisation comme medicament
WO2010055268A1 (fr) Nouveau procédé de préparation de granulés de principes actifs, et granulés tels qu'obtenus
EP0412877A1 (fr) Nouvelle forme galénique orale améliorant la biodisponibilité
BE1000087A3 (fr) Compositions pharmaceutiques contenant de la vinburnine et leur procede de preparation.